Enhanced response to repeated d-amphetamine challenge: Evidence for behavioral sensitization in humans

Biological Psychiatry

Volumn 40, Issue 9, 1996, Pages 872-880

  Strakowski, Stephen M ^a   Sax, Kenji W ^a   Setters, Mark J ^a   Keck Jr , Paul E ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Behavioral sensitization; d Amphetamine; Eye blinks; Human volunteers; Rating scales

Indexed keywords

AMPHETAMINE;

ADULT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; EYELID REFLEX; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; MOOD; MOTOR ACTIVITY; NORMAL HUMAN; PRIORITY JOURNAL; PROVOCATION TEST; SENSITIZATION;

EID: 0030297729     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-3223(95)00497-1     Document Type: Article

References (48)

1. American Psychiatric Association (1987): Diagnostic and Statistical Manual of Mental Disorders, 3rd ed rev, Washington DC: American Psychiatric Association.
2. Angrist B, Corwin J, Bartlik B, Cooper T (1987): Early pharmacokinetics and clinical effects of oral d-amphetamine in normal subjects. Biol Psychiatry 22:1357-1368.
3. Antelman SM, Eichler AJ, Black CA, Kocan D (1980): Interchangeability of stress and amphetamine in sensitization. Science 297:329-331.
4. Antelman SM, Caggiula AR, Knopf S, et al (1992): Amphetamine or haloperidol 2 weeks earlier antagonized the plasma corticosterone response to amphetamine; evidence for the stress/foreign nature of drugs. Psychopharmacology 107: 331-336.
5. Antelman SM, Kocan D, Edwards DJ, Knopf S (1989): Anticonvulsant and other effects of diazepam grow with time after a single treatment. Pharmacol Biochem Behav 33:31-39.
6. Antelman SM, Caggiula AR, Kocan D, et al (1991): One experience with 'lower' or 'higher' intensity stressors, respectively enhances or diminishes responsiveness to haloperidol weeks later: Implications for understanding drug variability. Brain Res 566:276-283.
7. Antelman SM, Chiodo LA (1983): Amphetamine as a stressor. In Creese I (ed), Stimulants: Neurochemical, Behavioral, and Clinical Perspectives. New York: Raven Press, pp 269-299.
8. Bell DS (1973): The experimental reproduction of amphetamine psychosis. Arch Gen Psychiatry 29:35-40.
9. Brady KT, Lydiard RB, Malcolm R, Ballenger JC (1991): Cocaine-induced psychosis. J Clin Psychiatry 52:509-512.
10. Carlson GA, Goodwin FK (1973): The stages of mania: A longitudinal analysis of the manic episode. Arch Gen Psychiatry 28:221-228.
11. Castaneda E, Becker JB, Robinson TE (1988): The long-term effects of repeated amphetamine treatment in vivo on amphetamine, KCL, and electrical stimulation evoked striatal dopamine release in vivo. Life Sci 42:2447-2456.
12. Connell PH (1958): Amphetamine Psychosis. Maudsley Monograph No. 5. London: Chapman & Hall Ltd.
13. Deutsch SI, Mastropaolo J, Schwartz BL, et al (1989): A "glutamatergic hypothesis" of schizophrenia. Clin Neuropharmacol 12:1-13.
14. Fibiger HC (1991): The dopamine hypothesis of schizophrenia and mood disorders. In P. Willner, J. Scheel-Kruger (eds.), The mesuliactic dopamine system: from motivation to action. Chichester, England: John Wiley & Sons.
15. Goldberg TE, Begelow LB, Weinberger DR, et al (1991): Cognitive and behavioral effects of the coadministration of dextroamphetamine and haloperidol in schizophrenia. Am J Psychiatry 148:78-84.
16. Goodwin FK, Jamison JR (1990): Manic-Depressive Illness. New York: Oxford University Press.
17. Griffith JD, Cavanaugh J, Held J, Oates JA (1972): Dextroamphetamine: Evaluation of psychomimetic properties in man. Arch Gen Psychiatry 26:97-100.
18. Jacobs D, Silverstone T (1986): Dextroamphetamine-induced arousal in human subjects as a model for mania. Psychol Med 16:323-329.
19. Kalivas PW, Duffy P (1988): Effects of daily cocaine and morphine treatment on somatodendritic and terminal field dopamine release. J Neurochem 50:1498-1504.
20. Karson CN (1983): Spontaneous eye-blink rates and dopaminergic systems. Brain 106:643-653.
21. Klawans HL, Margolin DI (1975): Amphetamine-induced dopaminergic hypersensitivity in guinea pigs. Arch Gen Psychiatry 32:725-732.
22. Klug JM, Norman AB (1993): Long-term sensitization of apomorphine-induced rotation behavior in rats with dopamine deafferentation or excitotoxin lesions of the striatum. Pharmacol Biochem Behav 46:397-403.
23. Kokkinidis L (1984): Effects of chronic intermittent and continuous amphetamine administration on acoustic startle. Pharmacol Biochem Behav 20:367-372.
24. Kuczenski R, Segal D (1989): Concomitant characterization of behavioral and striatal neurotransmitter response to amphetamine using in vivo microdialysis. J Neurosci 9:2051-2065.
25. McNair DM, Lorr M, Droppleman LF (1971): Manual for the Profile of Mood States. San Diego, CA: EITS.
26. Overall JE, Gorham DR (1962): The Brief Psychiatric Rating Scale. Psychol Rep 10:799-812.
27. 3H]-dopamine release. Pharmacol Biochem Behav 27:533-535.
28. Post RM (1992): Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. Am J Psychiatry 149:999-1010.
29. Rebec GV, Segal DS (1979): Enhanced responsiveness to intraventricular infusion of amphetamine following its repeated systemic administration. Psychopharmacology 13:263-286.
30. Reynolds GP (1989): Beyond the dopamine hypothesis: The neurochemical pathology of schizophrenia. Br J Psychiatry 155:305-326.
31. Robinson TE (1984): Behavioral sensitization: Characterization of enduring changes in rotational behavior produced by intermittent injections of amphetamine in male and female rats. Psychopharmacology 84:466-475.
32. Robinson TE, Becker JB (1986): Enduring changes in brain and behavior produced by chronic amphetamine administration: A review and evaluation of animal models of amphetamine psychosis. Brain Res Rev 11:157-198.
33. Robinson TE (1988): Stimulant drugs and stress: Factors influencing individual differences in the susceptibility to sensitization. In Kalivas PW, Barnes CD (eds), Sensitization in the Nervous System. Caldwell, NJ: Telford Press, pp 145-174.
34. Satel SL, Southwick SM, Gawin FH (1991): Clinical features of cocaine-induced paranoia. Am J Psychiatry 148:495-498.
35. Sato M, Chen CC, Akiyama K, Otsuki S (1983): Acute exacerbation of paranoid psychotic state after long-term abstinence in patients with previous methamphetamine psychosis. Biol Psychiatry 18:429-441.
36. Schenk S, Valadez A, McNamara C, et al (1993): Development and expression of sensitization to cocaine's reinforcing properties: Role of NMDA receptors. Psychopharmacol 111:332-338.
37. Siegal S (1977): Learning and psychopharmacology. In Jarvik ME (ed), Psychopharmacology in the Practice of Medicine. New York: Appleton-Century-Crofts.
38. Segal DS, Mandell AJ (1974): Long-term administration of amphetamine: Progressive augmentation of motor activity and stereotypy. Pharmacol Biochem Behav 2:249-255.
39. Segal DS, Schuckit MA (1983): Animal models of stimulant-induced psychosis. In Creese I (ed), Stimulants: Neurochemical, Behavioral, and Clinical Perspectives. New York, NY: Raven Press.
40. Segal DS, Geyer MA, Schuckit MA (1981): Stimulant-induced psychosis: An evaluation of animal models. In Youdim MBH, Lovenberg W, Sharman DF, Lagnado JR (eds), Essays in Neurochemistry and Neuropharmacology, Vol 5. London: John Wiley & Sons Ltd.
41. Shtasel DL, Gur RE, Mozley PD, et al (1991): Volunteers for biomedical research: Recruitment and screening of normal controls. Arch Gen Psychiatry 48:1022-1025.
42. Spitzer RL, Williams JBW, Gibbon M, First MG (1990): Structured Clinical Interview for DSM-III-R - Patient Version (SCID-P). New York: New York State Psychiatric Institute, Biometric Research.
43. Stevens J (1990): Intermediate Statistics: A Modern Approach. Hillsdale, NJ: Lawrence Erlbaum Associates.
44. Szechtman H, Cleghorn JM, Brown GM, et al (1988): Sensitization and tolerance to apomorphine in men: Yawning, growth hormone, nausea, and hyperthermia. Psychiatry Res 23:245-255.
45. Welkowitz J, Ewen RB, Cohen J (1976): Introductory Statistics for the Behavioral Sciences. New York: Academic Press.
46. Wolf M, Jeziorski M (1993): Coadministration of MK-801 with amphetamine, cocaine or morphine prevents rather than transiently masks the development of behavioral sensitization. Brain Res 613:291-294.
47. Yehuda R, Antelman SM (1993): Criteria for rationally evaluating animal models of posttraumatic stress disorder. Biol Psychiatry 33:479-486.
48. Young RC, Biggs JT, Ziegler VE, Meyer DA (1978): A rating scale for mania: Reliability, validity and sensitivity. Br J Psychiatry 133:429-435.